Current status and influencing factors of beliefs in taking antituberculosis drugs among young patients with newly treated pulmonary tuberculosis
10.3760/cma.j.cn115682-20230802-00318
- VernacularTitle:青年初治肺结核患者抗结核药物服药信念现状及影响因素分析
- Author:
Qian WU
1
;
Mengjie JIN
;
Tongxin SONG
;
En FAN
;
Li SHI
;
Meixin WANG
Author Information
1. 新疆医科大学护理学院，乌鲁木齐 830011
- Keywords:
Pulmonary tuberculosis;
Young patients;
Beliefs about medication;
Influencing factors
- From:
Chinese Journal of Modern Nursing
2024;30(10):1305-1310
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the level of beliefs about medication in young patients with newly treated pulmonary tuberculosis and analyze its influencing factors.Methods:This was a cross-sectional study. Using the convenient sampling method, a total of 320 young newly treated pulmonary tuberculosis patients who visited the designated tuberculosis hospitals in Kashgar Prefecture and Hotan Prefecture of Xinjiang Uygur Autonomous Region from January 2022 to April 2023 were selected as the research objects. The investigation was carried out with the General Information Questionnaire, Beliefs about Medicines Questionaire Specific (BMQ-S), 8-Item Morisky Medication Adherence Scale (MMAS-8), Brief Illness Perception Questionnaire (BIPQ) and Tuberculosis-related Stigma Scale (TSS). Multiple linear regression was used to analyze the influencing factors of medication beliefs in young patients with newly treated tuberculosis.Results:A total of 320 questionnaires were distributed in this study, and 302 valid questionnaires were collected, with an effective response rate of 94.38% (302/320). The total score of BMQ-S of 302 young patients with newly treated tuberculosis was -1.00 (-2.00, 1.00), MMAS-8 score was 5.38 (4.75, 5.75), BIPQ score was 37.00 (24.00, 44.00) and TSS score was 48.00 (44.00, 52.00). The results of multiple linear regression analysis showed that comorbidities, medication adherence, disease perception and stigma were the influencing factors of medication beliefs in young newly treated pulmonary tuberculosis patients ( P<0.01) . Conclusions:The medication belief level of young patients with newly treated pulmonary tuberculosis needs to be improved. Medical staff should correct the negative cognition of the patient's disease, emphasize the benefits of drug treatment and enhance the patients' beliefs in the necessity of medication.
